Christine Lundgren Selected Research

Breast Neoplasms (Breast Cancer)

4/2024	Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit.
1/2023	Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial.
5/2022	Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population: A Multicenter Study.
5/2022	PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
12/2020	Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
11/2019	Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.
7/2018	Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Lundgren Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 04/2024 - 07/2018
2	Neoplasms (Cancer) 01/2023 - 11/2019
1	Triple Negative Breast Neoplasms 12/2020

Drug/Important Bio-Agent (IBA)

4	Tamoxifen FDA LinkGeneric 04/2024 - 12/2020
3	Hormones (Hormone)IBA 04/2024 - 07/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2020
2	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2019
2	Phenobarbital (Luminal)FDA Link 05/2022 - 11/2019
1	Estrogen ReceptorsIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	ParaffinIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 05/2022
1	Adjuvant Chemotherapy 05/2022
1	Therapeutics 07/2018